An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: combination of distinct morphologic, immunohistochemical, and genetic features

被引:85
作者
Chen, Sung-Ting [1 ]
Lee, Jen-Chieh [1 ]
机构
[1] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Pathol, Taipei 10001, Taiwan
关键词
Inflammatory myofibroblastic tumor; Round cell transformation; RANBP2; ALK;
D O I
10.1016/j.humpath.2008.04.016
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
Inflammatory myofibroblastic tumor is an intermediate-grade neoplasm with potential for recurrence and rare metastasis. Rearrangement of the anaplastic lymphoma kinase gene with variable fusion partners and anaplastic lymphoma kinase expression using immunohistochemistry are noted ill about half of the tumors. We present a hepatic inflammatory myofibroblastic tumor from a 34-year-old man with all unusual rearrangement between the Ran binding protein 2 and anaplastic lymphoma kinase genes. as well as a peculiar round cell transformation of tumor cells and a unique nuclear membrane expression of anaplastic lymphoma kinase protein. As the fourth reported inflammatory myofibroblastic tumor with this Fusion so far. we find that these genetic and morphologic features may be related to a poor clinical outcome. The diagnostic difficulty and other prognostic factors of inflammatory myofibroblastic tumor are also discussed. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:1854 / 1858
页数:5
相关论文
共 13 条
[1]
Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: A study of 135 cases [J].
Cessna, MH ;
Zhou, H ;
Sanger, WG ;
Perkins, SL ;
Tripp, S ;
Pickering, D ;
Daines, C ;
Coffin, CM .
MODERN PATHOLOGY, 2002, 15 (09) :931-938
[2]
CHAN JKC, 1997, ADV ANAT PATHOL, V4, P387
[3]
Inflammatory myofibroblastic tumor - Comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases [J].
Coffin, Cheryl M. ;
Hornick, Jason L. ;
Fletcher, Christopher D. M. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (04) :509-520
[4]
Coffin CM, 2002, WHO CLASSIFICATION T, P91
[5]
Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor - A comparative immunohistochemical study [J].
Cook, JR ;
Dehner, LP ;
Collins, MH ;
Ma, ZG ;
Morris, SW ;
Coffin, CM ;
Hill, DA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (11) :1364-1371
[6]
Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor [J].
Cools, J ;
Wlodarska, I ;
Somers, R ;
Mentens, N ;
Pedeutour, F ;
Maes, B ;
De Wolf-Peeters, C ;
Pauwels, P ;
Hagemeijer, A ;
Marynen, P .
GENES CHROMOSOMES & CANCER, 2002, 34 (04) :354-362
[7]
ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor [J].
Debiec-Rychter, M ;
Marynen, P ;
Hagemeijer, A ;
Pauwels, P .
GENES CHROMOSOMES & CANCER, 2003, 38 (02) :187-190
[8]
Hussong JW, 1999, MODERN PATHOL, V12, P279
[9]
Expression of anaplastic lymphoma kinase in soft tissue tumors: An immunohistochemical and molecular study of 249 cases [J].
Li, XQ ;
Hisaoka, M ;
Shi, DR ;
Zhu, XZ ;
Hashimoto, H .
HUMAN PATHOLOGY, 2004, 35 (06) :711-721
[10]
Fusion of ALK to the ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor [J].
Ma, ZG ;
Hill, DA ;
Collins, MH ;
Morris, SW ;
Sumegi, J ;
Zhou, M ;
Zuppan, C ;
Bridge, JA .
GENES CHROMOSOMES & CANCER, 2003, 37 (01) :98-105